Clinical Study Results
The website listed at the end of this summary may have other information about
adverse reactions or other medical problems that happened during this study.
The 1 participant who left the study early is not included in the results below because
he did not take any study drug.
How many participants had serious adverse reactions?
None of the participants had serious adverse reactions during the study. None of the
participants died during the study.
How many participants had adverse reactions?
There were 21.6% of participants who had adverse reactions during the study. This
was 8 out of 37 participants.
There were 8.1% of participants who stopped taking AZD4831 because of adverse
reactions they had during the study. This was 3 out of 37 participants.
What adverse reactions did the participants have?
The most common adverse reactions were rash, headache, and dry throat.
Participants who took the highest AZD4831 dose had more adverse reactions than
participants who took the lower AZD4831 doses.
The adverse reactions below happened in 2 or more of the total number of
participants. There were other adverse reactions, but these happened in fewer
participants. The groups are presented in the order of increasing dose.
Most common adverse reactions during the study
Group 1 Group 4 Group 2 Group 3
Out of 8 Out of 8 Out of 8 Out of 5
participants participants participants participants
who took the who took the who took the who took the
lowest dose low dose high dose highest dose
of AZD4831 of AZD4831 of AZD4831 of AZD4831
Rash 0.0% (0) 0.0% (0) 25.0% (2) 40.0% (2)
Headache 0.0% (0) 12.5% (1) 0.0% (0) 20.0% (1)
Dry throat 0.0% (0) 0.0% (0) 12.5% (1) 20.0% (1)
5